Table 2.
Group | Cancer Type |
Educational level |
Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
JP | EAPC1 (95% CI) | EAPC2 (95% CI) | RR | 95%CI | JP | EAPC1 (95% CI) | EAPC2 (95% CI) | RR | 95%CI | |||
TOTAL CANCER | Primary | No | −0.77 (−1.39; −0.16) | 1.54 | (1.48; 1.59) | No | −1.49 (−1.98; −1.01) | 1.62 | (1.57; 1.68) | |||
Secondary | No | −1.35 (−1.81; −0.89) | 1.34 | (1.29; 1.39) | No | −1.26 (−2.07; −0.45) | 1.35 | (1.30; 1.40) | ||||
Tertiary | No | −1.43 (−2.79; −0.05) | 1 | No | −1.59 (−3.16; −0.01) | 1 | ||||||
| ||||||||||||
Infection related cancers | Stomach | Primary | No | −1.13 (−2.05; −0.19) | 2.56 | (2.29; 2.86) | No | −1.28 (−3.07; 0.54) | 1.98 | (1.75; 2.24) | ||
Secondary | No | −1.17 (−2.74; 0.43) | 1.65 | (1.47; 1.85) | No | −2.68 (−5.75; 0.50) | 1.38 | (1.21; 1.59) | ||||
Tertiary | No | 0.63 (−2.63; 4.01) | 1 | No | −0.33 (−7.07; 6.90) | 1 | ||||||
Cervix | Primary | n.a. | No | −3.53 (−4.65; −2.40) | 5.75 | (5.05; 6.54) | ||||||
Secondary | n.a. | No | −2.08 (−3.54; −0.59) | 2.82 | (2.47; 3.22) | |||||||
Tertiary | n.a. | No | −2.33 (−7.43; 3.06) | 1 | ||||||||
| ||||||||||||
Cancers related to other risk factors | Prostate | Primary | No | −2.45 (−4.57; −0.28) | 1.04 | (0.92; 1.19) | n.a. | |||||
Secondary | No | −3.74 (−6.38; −1.03) | 1.01 | (0.87; 1.16) | n.a. | |||||||
Tertiary | No | −3.37 (−10.51; 4.33) | 1 | n.a. | ||||||||
Lung | Primary | No | −0.15 (−1.16; 0.88) | 1.64 | (1.47; 1.82) | No | −0.84 (−2.51; 0.86) | 1.32 | (1.16; 1.50) | |||
Secondary | 2002 | 1.69 (−1.59; 5.09) | −3.70 (−5.55; −1.81) | 1.38 | (1.22; 1.55) | No | −1.42 (−4.16; 1.41) | 1.12 | (0.98; 1.28) | |||
Tertiary | No | −3.01 (−7.09: 1.25) | 1 | No | 0.49 (−4.47; 5.72) | 1 | ||||||
Colorectal | Primary | No | 1.67 (−0.44: 3.82) | 0.91 | (0.82; 1.01) | No | 1.38 (−0.07; 2.85) | 1.01 | (0.90; 1.13) | |||
Secondary | No | 0.31 (−2.12; 2.81) | 1.05 | (0.93; 1.19) | No | −0.11 (−1.64; 1.45) | 1.13 | (0.99; 1.28) | ||||
Tertiary | No | −3.36 (−8.08; 1.61) | 1 | No | 1.31 (−3.59; 6.45) | 1 | ||||||
Breast | Primary | n.a. | No | 0.71 (−0.61; 2.05) | 0.93 | (0.87; 0.99) | ||||||
Secondary | n.a. | No | −0.20 (−1.96; 1.58) | 1.13 | (1.06; 1.21) | |||||||
Tertiary | n.a. | No | 0.03 (−4.18; 4.43) | 1 | ||||||||
| ||||||||||||
OTHER CANCERS | Primary | No | −0.88 (−1.67; −0.08) | 1.39 | (1.33; 1.45) | No | −1.64 (−2.16; −1.12) | 1.50 | (1.43; 1.57) | |||
Secondary | No | −1.34 (−2.21; −0.47) | 1.30 | (1.24; 1.37) | No | −1.60 (−2.54; −0.65) | 1.27 | (1.21; 1.34) | ||||
Tertiary | 2001 | −6.48 (−13.14; 0.69) | 0.87 (−1.30; 3.09) | 1 | No | −3.10 (−5.02; −1.13) | 1 |
JP = joinpoint: was there a joinpoint and if so, in which year; EAPC = Estimated Annual Percent Change (%), EAPC1: EAPC during period from 1998 until joinpoint (in case of a joinpoint) or during the whole period, EAPC2: EAPC during the period from joinpoint until 2007; RR = Rate Ratio, apply to period 1998–2007; n.a. = not applicable